Bridge City Capital’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-13,740
Closed -$5.66M 115
2024
Q2
$5.66M Sell
13,740
-4,816
-26% -$1.91M 1.9% 10
2024
Q1
$7.5M Sell
18,556
-3,477
-16% -$1.22M 2.73% 2
2023
Q4
$6.75M Buy
22,033
+1,263
+6% +$341K 2.62% 3
2023
Q3
$5.03M Sell
20,770
-140
-0.7% -$35.8K 2.54% 3
2023
Q2
$5.02M Buy
20,910
+12
+0.1% +$2.49K 2.38% 4
2023
Q1
$3.93M Sell
20,898
-80
-0.4% -$16.5K 1.97% 6
2022
Q4
$4.46M Sell
20,978
-3,942
-16% -$788K 2.29% 5
2022
Q3
$3.92M Buy
24,920
+807
+3% +$129K 2.15% 5
2022
Q2
$3.61M Buy
24,113
+3,837
+19% +$555K 1.91% 6
2022
Q1
$3.32M Sell
20,276
-104
-0.5% -$17.1K 1.55% 16
2021
Q4
$4.44M Sell
20,380
-8
-0% -$1.68K 1.83% 9
2021
Q3
$3.86M Sell
20,388
-5,441
-21% -$992K 1.75% 8
2021
Q2
$4.56M Sell
25,829
-885
-3% -$153K 1.56% 12
2021
Q1
$4.38M Sell
26,714
-270
-1% -$41.3K 1.45% 17
2020
Q4
$3.76M Buy
26,984
+5,484
+26% +$691K 1.43% 24
2020
Q3
$2.4M Sell
21,500
-2,080
-9% -$241K 1.15% 44
2020
Q2
$2.19M Sell
23,580
-3,700
-14% -$315K 1.01% 53
2020
Q1
$2M Buy
+27,280
New +$2.37M 0.97% 50

Other funds holding MEDP

Bridge City Capital's MEDP Position: Q3 2024 in Review

Bridge City Capital sold out of Medpace (MEDP) in Q3 2024, closing a stake of 13,740 shares — an estimated $5.66M sold.

Bridge City Capital first reported a position in MEDP in Q1 2020 and held it in 18 quarters. The position peaked at $7.5M in Q1 2024. 583 funds tracked by Wall St. Rank hold MEDP as of Q3 2024.

  • Bridge City Capital reported no remaining Medpace position as of Q3 2024 after selling out during the quarter.
  • Bridge City Capital sold 13,740 Medpace shares in Q3 2024, an estimated $5.66M.
  • Bridge City Capital first reported a position in Medpace in Q1 2020 and held it in 18 quarters.
  • Bridge City Capital's Medpace position peaked at $7.5M in Q1 2024.
  • 583 funds tracked by Wall St. Rank held Medpace as of Q3 2024.

Based on Bridge City Capital's 13F filing for Q3 2024, filed 14 Nov 2024.